Cargando…
Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis
PURPOSE: This study was conducted to evaluate outcomes in adult patients with Burkitt lymphoma (BL) or Burkitt-like lymphoma treated with an rituximab plus hyper-CVAD (R-hyper-CVAD) regimen by focusing on tolerability and actual delivered relative dose intensity (RDI). MATERIALS AND METHODS: Patient...
Autores principales: | Hong, Junshik, Kim, Seok Jin, Ahn, Jae-Sook, Song, Moo Kon, Kim, Yu Ri, Lee, Ho Sup, Yhim, Ho-Young, Yoon, Dok Hyun, Kim, Min Kyoung, Oh, Sung Yong, Park, Yong, Mun, Yeung-Chul, Do, Young Rok, Ryoo, Hun-Mo, Lee, Je-Jung, Lee, Jae Hoon, Kim, Won Seog, Suh, Cheolwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398112/ https://www.ncbi.nlm.nih.gov/pubmed/25544581 http://dx.doi.org/10.4143/crt.2014.055 |
Ejemplares similares
-
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
por: Samra, Bachar, et al.
Publicado: (2021) -
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels
por: Kim, Hyung-Don, et al.
Publicado: (2021) -
Sixth nerve palsy in sporadic Burkitt Lymphoma
por: Yennam, Sowmya, et al.
Publicado: (2019) -
Clinical Aspects and Therapy of Sporadic Burkitt Lymphoma
por: Pagano, Livio, et al.
Publicado: (2009) -
Clinicopathological Study of Sporadic Burkitt Lymphoma in Children
por: Huang, Hui, et al.
Publicado: (2015)